Norethisterone acetate in the treatment of advanced breast cancer
- PMID: 954799
- DOI: 10.1016/0014-2964(76)90163-8
Norethisterone acetate in the treatment of advanced breast cancer
Similar articles
-
Norethisterone acetate (SH420) in advanced breast cancer.Cancer. 1973 Dec;32(6):1317-20. doi: 10.1002/1097-0142(197312)32:6<1317::aid-cncr2820320604>3.0.co;2-a. Cancer. 1973. PMID: 4757921 No abstract available.
-
[Progestogens in the treatment of advanced breast cancer. Clinical study of norethisterone acetate].Sem Hop. 1970 Jan 14;46(3):170-88. Sem Hop. 1970. PMID: 4313239 French. No abstract available.
-
[Treatment of bone metastases of breast cancer with progestogens].Rev Rhum Mal Osteoartic. 1974 Jan;41(1):29-32. Rev Rhum Mal Osteoartic. 1974. PMID: 4820523 French.
-
Norethisterone acetate in the treatment of advanced breast cancer.Clin Oncol. 1984 Jun;10(2):103-9. Clin Oncol. 1984. PMID: 6734001
-
Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A review.Am J Obstet Gynecol. 2002 Oct;187(4):1101-16. doi: 10.1067/mob.2002.122852. Am J Obstet Gynecol. 2002. PMID: 12389012 Review.
Cited by
-
High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapy.Cancer Chemother Pharmacol. 1979;2(3):175-80. doi: 10.1007/BF00258291. Cancer Chemother Pharmacol. 1979. PMID: 455571 No abstract available.